You are here

• Home
• Drug Products
• All Drug Products

• Non-interventional observational study to evaluate change of PSA levels in patients with advanced prostate cancer treated with bicalutamide in combination with medical or surgical castration

Disease

prostate cancer

Drug Name

Casodex

Generic Name

bicalutamide

Sponsor

AstraZeneca

Drug Status

Approved Medicine

Phase

Non-Interventional Study

Start Date

Jan 2, 1960

Study Name

NIS-OHR-CAS-2008/1

Study Id

NIS-OHR-CAS-2008/1

ClinicalTrials.gov ID

NCT00871585

Recruiting Status

Open

Protocol Status

Not Available

Report

Jan 1, 2011

• NIS-OHR-CAS-2008/1.pdf (227 KB)

Page tools

• Print
• Bookmark this page